Literature DB >> 22393262

Glycomic and proteomic profiling of pancreatic cyst fluids identifies hyperfucosylated lactosamines on the N-linked glycans of overexpressed glycoproteins.

Benjamin F Mann1, John A Goetz, Michael G House, C Max Schmidt, Milos V Novotny.   

Abstract

Pancreatic cancer is now the fourth leading cause of cancer deaths in the United States, and it is associated with an alarmingly low 5-year survival rate of 5%. However, a patient's prognosis is considerably improved when the malignant lesions are identified at an early stage of the disease and removed by surgical resection. Unfortunately, the absence of a practical screening strategy and clinical diagnostic test for identifying premalignant lesions within the pancreas often prevents early detection of pancreatic cancer. To aid in the development of a molecular screening system for early detection of the disease, we have performed glycomic and glycoproteomic profiling experiments on 21 pancreatic cyst fluid samples, including fluids from mucinous cystic neoplasms and intraductal papillary mucinous neoplasms, two types of mucinous cysts that are considered high risk to undergo malignant transformation. A total of 80 asparagine-linked (N-linked) glycans, including high mannose and complex structures, were identified. Of special interest was a series of complex N-linked glycans containing two to six fucose residues, located predominantly as substituents on β-lactosamine extensions. Following the observation of these "hyperfucosylated" glycans, bottom-up proteomics experiments utilizing a label-free quantitative approach were applied to the investigation of two sets of tryptically digested proteins derived from the cyst fluids: 1) all soluble proteins in the raw samples and 2) a subproteome of the soluble cyst fluid proteins that were selectively enriched for fucosylation through the use of surface-immobilized Aleuria aurantia lectin. A comparative analysis of these two proteomic data sets identified glycoproteins that were significantly enriched by lectin affinity. Several candidate glycoproteins that appear hyperfucosylated were identified, including triacylglycerol lipase and pancreatic α-amylase, which were 20- and 22-fold more abundant, respectively, following A. aurantia lectin enrichment.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22393262      PMCID: PMC3394951          DOI: 10.1074/mcp.M111.015792

Source DB:  PubMed          Journal:  Mol Cell Proteomics        ISSN: 1535-9476            Impact factor:   5.911


  49 in total

1.  Practice guidelines in acute pancreatitis.

Authors:  Peter A Banks; Martin L Freeman
Journal:  Am J Gastroenterol       Date:  2006-10       Impact factor: 10.864

2.  Glycosylation of serum ribonuclease 1 indicates a major endothelial origin and reveals an increase in core fucosylation in pancreatic cancer.

Authors:  Sílvia Barrabés; Lluís Pagès-Pons; Catherine M Radcliffe; Glòria Tabarés; Esther Fort; Louise Royle; David J Harvey; Michel Moenner; Raymond A Dwek; Pauline M Rudd; Rafael De Llorens; Rosa Peracaula
Journal:  Glycobiology       Date:  2007-01-17       Impact factor: 4.313

3.  Classification of pancreatic cystic lesions using SELDI-TOF mass spectrometry.

Authors:  Christopher J Scarlett; Jaswinder S Samra; Aiqun Xue; Robert C Baxter; Ross C Smith
Journal:  ANZ J Surg       Date:  2007-08       Impact factor: 1.872

4.  Alterations in the serum glycome due to metastatic prostate cancer.

Authors:  Zuzana Kyselova; Yehia Mechref; Mohammad M Al Bataineh; Lacey E Dobrolecki; Robert J Hickey; Jake Vinson; Christopher J Sweeney; Milos V Novotny
Journal:  J Proteome Res       Date:  2007-04-14       Impact factor: 4.466

5.  Fucosylated haptoglobin is a novel marker for pancreatic cancer: a detailed analysis of the oligosaccharide structure and a possible mechanism for fucosylation.

Authors:  Noriko Okuyama; Yoshihito Ide; Miyako Nakano; Tsutomu Nakagawa; Kanako Yamanaka; Kenta Moriwaki; Kohei Murata; Hiroaki Ohigashi; Shigekazu Yokoyama; Hidetoshi Eguchi; Osamu Ishikawa; Toshifumi Ito; Michio Kato; Akinori Kasahara; Sunao Kawano; Jianguo Gu; Naoyuki Taniguchi; Eiji Miyoshi
Journal:  Int J Cancer       Date:  2006-06-01       Impact factor: 7.396

6.  Characterization of cystic pancreatic masses: relative accuracy of CT and MRI.

Authors:  Brendan C Visser; Benjamin M Yeh; Aliya Qayyum; Lawrence W Way; Charles E McCulloch; Fergus V Coakley
Journal:  AJR Am J Roentgenol       Date:  2007-09       Impact factor: 3.959

Review 7.  Biological function of fucosylation in cancer biology.

Authors:  Eiji Miyoshi; Kenta Moriwaki; Tsutomu Nakagawa
Journal:  J Biochem       Date:  2008-01-24       Impact factor: 3.387

8.  Chymotrypsin C (caldecrin) promotes degradation of human cationic trypsin: identity with Rinderknecht's enzyme Y.

Authors:  Richárd Szmola; Miklós Sahin-Tóth
Journal:  Proc Natl Acad Sci U S A       Date:  2007-06-25       Impact factor: 11.205

9.  Breast cancer diagnosis and prognosis through quantitative measurements of serum glycan profiles.

Authors:  Zuzana Kyselova; Yehia Mechref; Pilsoo Kang; John A Goetz; Lacey E Dobrolecki; George W Sledge; Lauren Schnaper; Robert J Hickey; Linda H Malkas; Milos V Novotny
Journal:  Clin Chem       Date:  2008-05-16       Impact factor: 8.327

10.  Glycoprotein microarrays with multi-lectin detection: unique lectin binding patterns as a tool for classifying normal, chronic pancreatitis and pancreatic cancer sera.

Authors:  Jia Zhao; Tasneem H Patwa; Weilian Qiu; Kerby Shedden; Robert Hinderer; David E Misek; Michelle A Anderson; Diane M Simeone; David M Lubman
Journal:  J Proteome Res       Date:  2007-04-12       Impact factor: 4.466

View more
  23 in total

Review 1.  Tools for label-free peptide quantification.

Authors:  Sven Nahnsen; Chris Bielow; Knut Reinert; Oliver Kohlbacher
Journal:  Mol Cell Proteomics       Date:  2012-12-17       Impact factor: 5.911

Review 2.  High-sensitivity analytical approaches for the structural characterization of glycoproteins.

Authors:  William R Alley; Benjamin F Mann; Milos V Novotny
Journal:  Chem Rev       Date:  2013-03-27       Impact factor: 60.622

Review 3.  Glycoprotein disease markers and single protein-omics.

Authors:  Kevin Chandler; Radoslav Goldman
Journal:  Mol Cell Proteomics       Date:  2013-02-11       Impact factor: 5.911

4.  Fucosylation is associated with the malignant transformation of intraductal papillary mucinous neoplasms: a lectin microarray-based study.

Authors:  Kiminori Watanabe; Masayuki Ohta; Kazuhiro Yada; Yoko Komori; Yukio Iwashita; Kenji Kashima; Masafumi Inomata
Journal:  Surg Today       Date:  2016-01-11       Impact factor: 2.549

5.  Complementary Glycomic Analyses of Sera Derived from Colorectal Cancer Patients by MALDI-TOF-MS and Microchip Electrophoresis.

Authors:  Christa M Snyder; William R Alley; Margit I Campos; Martin Svoboda; John A Goetz; Jaqueline A Vasseur; Stephen C Jacobson; Milos V Novotny
Journal:  Anal Chem       Date:  2016-09-13       Impact factor: 6.986

Review 6.  Proteomics analysis of bodily fluids in pancreatic cancer.

Authors:  Sheng Pan; Teresa A Brentnall; Ru Chen
Journal:  Proteomics       Date:  2015-04-27       Impact factor: 3.984

7.  Specific glycoforms of MUC5AC and endorepellin accurately distinguish mucinous from nonmucinous pancreatic cysts.

Authors:  Zheng Cao; Kevin Maupin; Bryan Curnutte; Brian Fallon; Christa L Feasley; Elizabeth Brouhard; Richard Kwon; Christopher M West; John Cunningham; Randall Brand; Paola Castelli; Stefano Crippa; Ziding Feng; Peter Allen; Diane M Simeone; Brian B Haab
Journal:  Mol Cell Proteomics       Date:  2013-07-08       Impact factor: 5.911

8.  Sub 2-μm macroporous silica particles derivatized for enhanced lectin affinity enrichment of glycoproteins.

Authors:  Benjamin F Mann; Amanda K P Mann; Sara E Skrabalak; Milos V Novotny
Journal:  Anal Chem       Date:  2013-01-17       Impact factor: 6.986

9.  Site-specific glycoforms of haptoglobin in liver cirrhosis and hepatocellular carcinoma.

Authors:  Petr Pompach; Zuzana Brnakova; Miloslav Sanda; Jing Wu; Nathan Edwards; Radoslav Goldman
Journal:  Mol Cell Proteomics       Date:  2013-02-06       Impact factor: 5.911

10.  Quantitative liquid chromatography-mass spectrometry-multiple reaction monitoring (LC-MS-MRM) analysis of site-specific glycoforms of haptoglobin in liver disease.

Authors:  Miloslav Sanda; Petr Pompach; Zuzana Brnakova; Jing Wu; Kepher Makambi; Radoslav Goldman
Journal:  Mol Cell Proteomics       Date:  2013-02-06       Impact factor: 5.911

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.